Author details

Full Name

Joshua J Waterfall

Affiliation

INSERM U, PSL Research University, Institut Curie Research Center

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36735774	Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer.	Sci Immunol	2023
37708024	Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma.	Cell Rep	2023
37863903	Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.	Nat Commun	2023
36879128	Evolution of synchronous female bilateral breast cancers and response to treatment.	Nat Med	2023
37444642	Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors.	Cancers (Basel)	2023
37253849	Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.	Nat Commun	2023
36735776	Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elements.	Sci Immunol	2023
36735774	Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer.	Sci Immunol	2023
37863903	Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.	Nat Commun	2023
37708024	Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma.	Cell Rep	2023
37253849	Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.	Nat Commun	2023
37444642	Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors.	Cancers (Basel)	2023
36879128	Evolution of synchronous female bilateral breast cancers and response to treatment.	Nat Med	2023
36735776	Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elements.	Sci Immunol	2023
35768432	CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.	Nat Commun	2022
35768432	CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.	Nat Commun	2022
35550257	Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions.	Mol Cell	2022
35550257	Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions.	Mol Cell	2022
33079397	Immune responses in genomically simple SWI/SNF-deficient cancers.	Cancer	2021
33811047	Splicing Patterns in <i>SF3B1</i>-Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific Neoepitopes.	Cancer Discov	2021
33514641	Contribution of resident and circulating precursors to tumor-infiltrating CD8<sup>+</sup> T cell populations in lung cancer.	Sci Immunol	2021
34325056	Identification of Tissue of Origin and Guided Therapeutic Applications in Cancers of Unknown Primary Using Deep Learning and RNA Sequencing (TransCUPtomics).	J Mol Diagn	2021
33079397	Immune responses in genomically simple SWI/SNF-deficient cancers.	Cancer	2021
33057152	Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers.	Oncogene	2021
33514641	Contribution of resident and circulating precursors to tumor-infiltrating CD8<sup>+</sup> T cell populations in lung cancer.	Sci Immunol	2021
33811047	Splicing Patterns in <i>SF3B1</i>-Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific Neoepitopes.	Cancer Discov	2021
34325056	Identification of Tissue of Origin and Guided Therapeutic Applications in Cancers of Unknown Primary Using Deep Learning and RNA Sequencing (TransCUPtomics).	J Mol Diagn	2021
33057152	Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers.	Oncogene	2021
32001692	Author Correction: Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans.	Nat Commun	2020
32001692	Author Correction: Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans.	Nat Commun	2020
30872698	Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells.	Sci Rep	2019
31844068	Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans.	Nat Commun	2019
31708437	Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors.	Cancer Cell	2019
30872698	Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells.	Sci Rep	2019
31227496	Evolutionary Routes in Metastatic Uveal Melanomas Depend on <i>MBD4</i> Alterations.	Clin Cancer Res	2019
31844068	Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans.	Nat Commun	2019
31708437	Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors.	Cancer Cell	2019
31227496	Evolutionary Routes in Metastatic Uveal Melanomas Depend on <i>MBD4</i> Alterations.	Clin Cancer Res	2019
29326266	The epigenetic control of stemness in CD8<sup>+</sup> T cell fate commitment.	Science	2018
29959327	Harnessing synthetic lethality to predict the response to cancer treatment.	Nat Commun	2018
29533779	A Non-canonical Polycomb Dependency in Synovial Sarcoma.	Cancer Cell	2018
29706636	Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients.	Eur J Hum Genet	2018
29326266	The epigenetic control of stemness in CD8<sup>+</sup> T cell fate commitment.	Science	2018
29632643	Analysis of the 9p21.3 sequence associated with coronary artery disease reveals a tendency for duplication in a CAD patient.	Oncotarget	2018
29959327	Harnessing synthetic lethality to predict the response to cancer treatment.	Nat Commun	2018
29632643	Analysis of the 9p21.3 sequence associated with coronary artery disease reveals a tendency for duplication in a CAD patient.	Oncotarget	2018
29533779	A Non-canonical Polycomb Dependency in Synovial Sarcoma.	Cancer Cell	2018
29706636	Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients.	Eur J Hum Genet	2018
28648284	Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.	Cancer Cell	2017
28648284	Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.	Cancer Cell	2017

1 - 50 of 94

Julian M Hess

Broad Institute of MIT and Harvard

Career Start Year 2015

Number of shared co-authors 1

Alex Murison

Princess Margaret Cancer Centre, University Health Network

Career Start Year 2012

Number of shared co-authors 0

Richard de Borja

The Hospital for Sick Children

Career Start Year 2012

Number of shared co-authors 5

Robert Siddaway

Hospital for Sick Children

Career Start Year 2011

Number of shared co-authors 0

Rahul K Kollipara

McDermott Center for Human Growth and Development.

Career Start Year 2010

Number of shared co-authors 0

Sebastian M Waszak

University of California san francisco

Career Start Year 2010

Number of shared co-authors 8

Richard Mitter

The Francis Crick Institute

Career Start Year 2008

Number of shared co-authors 0

Ignaty Leshchiner

Broad Institute of Massachusetts Institute of Technology and Harvard

Career Start Year 2008

Number of shared co-authors 2

Moritz Gerstung

German Cancer Research Centre DKFZ

Career Start Year 2007

Number of shared co-authors 2

Siyuan Zheng

Greehey Children's Cancer Research Institute

Career Start Year 2007

Number of shared co-authors 3

Xiaotu Ma

St. Jude Children's Research Hospital

Career Start Year 2006

Number of shared co-authors 6

Yue Lu

The University of Texas MD Anderson Cancer Center

Career Start Year 2006

Number of shared co-authors 0

Richard Koche

Memorial Sloan Kettering Cancer Center

Career Start Year 2005

Number of shared co-authors 3

Henry Yang

Cancer Science Institute of Singapore, National University of Singapore

Career Start Year 2005

Number of shared co-authors 0

Jamie K Teer

H. Lee Moffitt Cancer Center and Research Institute

Career Start Year 2005

Number of shared co-authors 10

Christopher A Bristow

The University of Texas MD Anderson Cancer Center

Career Start Year 2005

Number of shared co-authors 1

Chip Stewart

Broad Institute of MIT and Harvard

Career Start Year 2004

Number of shared co-authors 1

Joachim Weischenfeldt

University of Copenhagen

Career Start Year 2004

Number of shared co-authors 1

Matthias Schlesner

University of Augsburg

Career Start Year 2004

Number of shared co-authors 5

Amy G Robertson

Present address: Dxige Research Inc.

Career Start Year 2003

Number of shared co-authors 5

Jianmin Wang

Roswell Park Comprehensive Cancer Center

Career Start Year 2003

Number of shared co-authors 0

Peter Van Loo

The Francis Crick Institute

Career Start Year 2003

Number of shared co-authors 3

Olivier Elemento

Meyer Cancer Center

Career Start Year 2002

Number of shared co-authors 1

Luciano G Martelotto

Monash University

Career Start Year 2000

Number of shared co-authors 1

Gad Getz

Broad Institute of the Massachusetts Institute of Technology and Harvard

Career Start Year 2000

Number of shared co-authors 5

Andrew J Gentles

Stanford Center for Biomedical Informatics Research, Stanford University

Career Start Year 1999

Number of shared co-authors 0

Xiang Chen

St. Jude Children's Research Hospital

Career Start Year 1999

Number of shared co-authors 6

Carrie Sougnez

The Broad Institute of Harvard and MIT

Career Start Year 1998

Number of shared co-authors 4

Li Ding

McDonnell Genome Institute, Washington University School of Medicine

Career Start Year 1997

Number of shared co-authors 7

Glenn S Cowley

Broad Institute of Harvard and MIT

Career Start Year 1990

Number of shared co-authors 1

row(s) 1 - 30 of 30

Paul S Meltzer

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 20

Robert L Walker

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 8

Marbin Pineda

Center for Cancer Research, National Cancer Institute

Co-authored papers 7

Ga??lle Pierron

Institut Curie Hospital

Co-authored papers 7

Jonathan K Killian

From Foundation Medicine

Co-authored papers 7

Yuelin J Zhu

National Cancer Institute, National Institutes of Health

Co-authored papers 6

Franck Bourdeaut

SIREDO Oncology Center, Institut Curie Hospital, and Universite de Paris

Co-authored papers 5

Fergal Casey

Biogen Inc.

Co-authored papers 5

Holly Stevenson

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 5

Olivier Delattre

PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie

Co-authored papers 4

William I Smith

Suburban Hospital Department of Pathology

Co-authored papers 4

Susan R Davis

Co-authored papers 4

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Co-authored papers 4

Damarys Loew

Institut Curie, PSL Research University

Co-authored papers 4

Didier Surdez

Balgrist University Hospital, University of Zurich (UZH)

Co-authored papers 3

Julien Masliah-Planchon

Curie Institute Hospital Group

Co-authored papers 3

Celio Pouponnot

Institut Curie